AxioMed has completed collection and analysis of 2-year follow-up data in its U.S. Investigational Device Exemption clinical study of the Freedom viscoelastic lumbar disc.
The device received CE Mark approval in 2009, and has been used to treat >500 patients with follow-up exceeding 7 years. The company is seeking FDA Premarket Approval of the Freedom lumbar disc replacement within 2017.
AxioMed has completed collection and analysis of 2-year follow-up data in its U.S. Investigational Device Exemption clinical study of the Freedom viscoelastic lumbar disc.
The device received CE Mark approval in 2009, and has been used to treat >500 patients with...
AxioMed has completed collection and analysis of 2-year follow-up data in its U.S. Investigational Device Exemption clinical study of the Freedom viscoelastic lumbar disc.
The device received CE Mark approval in 2009, and has been used to treat >500 patients with follow-up exceeding 7 years. The company is seeking FDA Premarket Approval of the Freedom lumbar disc replacement within 2017.
Copy to clipboard 
